Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »
Text size Getty Images Vestas Wind Systems‘s stock hit record highs on Tuesday as strong demand in the US for wind turbines in the second quarter drove upward sales. The world’s largest wind turbine manufacturer restored its lead year-on-year as sales rose to € 3.5 billion – a 67% increase …
Read More »
Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …
Read More »
Text size CEO of Ericsson Börje Ekholm (Per Myrehed). Shares in Ericsson soared more than 10% on Friday, after the Swedish telecoms company reported higher-than-expected second-quarter earnings, fueled by an increase in 5G network sales and software revenue. The back story. Ericsson has made a recovery under Börje Ekholm, who …
Read More »
Text size Goldman Sachs analyst Fei Fang downgraded US depositary receipts from Chinese electric vehicle maker NIO to Sell from Hold. ADRs are falling on Friday, but that’s after nearly doubling in the past month. Photography by Giulia Marchi / Bloomberg Recovery of a stock of electric vehicles has gone …
Read More »